|
2024
|
G/S
|
Medical and scientific research and development in the field of diagnosis and treatment of neuro-... |
|
|
G/S
|
Therapeutics and clinical programs targeting neuro-psychological disorders, autism, metabolic and... |
|
|
Invention
|
Liquid resin extended-release oral naltrexone formulation for treating autism-related disorders. ... |
|
|
Invention
|
Monohydrate salt of denatonium acetate.
There is disclosed a novel monohydrate salt form of dena... |
|
2023
|
Invention
|
Isoflavonoid compounds and methods for the treatment of cancer.
Provided herein is a pharmaceuti... |
|
|
Invention
|
Isoflavonoid compositions and methods for the treatment of cancer.
Provided herein is a pharmace... |
|
|
Invention
|
Improved abuse-deterrent pharmaceutical composition with aversion properties. There is disclosed ... |
|
2022
|
Invention
|
Monohydrate salt of denatonium acetate. There is disclosed a novel monohydrate salt form of denat... |
|
|
Invention
|
Pharmaceutical composition for treatment or prevention of multiple inflammatory disorders.
There... |
|
|
Invention
|
Combination of bitter receptor agonist and gut-signaling compound.
There is disclosed a combinat... |
|
|
Invention
|
Combination of bitter receptor agonist and gut-signaling compound. There is disclosed a combinati... |
|
|
Invention
|
Combination of bitter receptor agonist and gut-signaling compound. i.e.i.ei.e., a gut-signaling p... |
|
|
Invention
|
Oral pharmaceutical immediate release composition and method of treatment for weight loss.
There... |
|
|
Invention
|
Denatonium salt for use in preventing, preventing progression and treating fatty liver diseases. ... |
|
2021
|
Invention
|
Combination therapies.
Provided herein are compositions, methods, and kits for treating cancer c... |
|
|
Invention
|
Compositions and methods of treating cognitive impairment. The present invention relates generall... |
|
|
Invention
|
Method for treating sars and treating or preventing ards.
There is disclosed compositions and me... |
|
|
Invention
|
Method for treating sars and treating or preventing ards. There is disclosed compositions and met... |
|
|
Invention
|
Combination therapies.
Provided herein are methods of treating and sensitizing cancer comprising... |
|
|
Invention
|
Isoflavonoid compositions and methods for the treatment of cancer. Provided herein is a pharmaceu... |
|
2020
|
Invention
|
Pharmaceutical composition for treatment or prevention of multiple inflammatory disorders. There ... |
|
|
Invention
|
Oral pharmaceutical immediate release composition.
There is disclosed an oral pharmaceutical com... |
|
|
Invention
|
Oral pharmaceutical immediate release composition and method of treatment for weight loss. There ... |
|
|
Invention
|
Isoflavonoid compounds and methods for the treatment of cancer. Provided herein is a pharmaceutic... |
|
2019
|
Invention
|
Abuse deterrent formulations of amphetamine. The present invention relates generally to abuse-det... |
|
|
Invention
|
Oral pharmaceutical formulations of bitter compounds for pulmonary hypertension.
There is disclo... |
|
|
Invention
|
Oral pharmaceutical formulations of bitter compounds for pulmonary hypertension. There is disclos... |
|
|
Invention
|
Oral pharmaceutical formulations of bitter compounds for asthma.
There is disclosed an oral phar... |
|
|
Invention
|
Oral pharmaceutical formulations of bitter compounds for asthma. There is disclosed an oral pharm... |
|
|
Invention
|
Personalized treatment method for congestive heart failure. There is disclosed a personalized tre... |
|
2018
|
Invention
|
Oral pharmaceutical formulation for weight loss, diabetes and related disorders. There is disclos... |
|
2016
|
Invention
|
Combination therapies. Provided herein are methods of treating and sensitizing cancer comprising ... |
|
2009
|
Invention
|
Substituted chroman derivatives, medicaments and use in therapy. Novel substituted chroman deriva... |
